Department of Medicine, The University of Chicago, Chicago, IL, 60637, USA.
Department of Surgery, The University of Chicago, Chicago, IL, 60637, USA.
Cell Mol Immunol. 2019 Apr;16(4):324-333. doi: 10.1038/s41423-019-0203-7. Epub 2019 Feb 13.
Donor-specific transplantation tolerance that enables weaning from immunosuppressive drugs but retains immune competence to non-graft antigens has been a lasting pursuit since the discovery of neonatal tolerance. More recently, efforts have been devoted not only to understanding how transplantation tolerance can be induced but also the mechanisms necessary to maintain it as well as how inflammatory exposure challenges its durability. This review focuses on recent advances regarding key peripheral mechanisms of T cell tolerance, with the underlying hypothesis that a combination of several of these mechanisms may afford a more robust and durable tolerance and that a better understanding of these individual pathways may permit longitudinal tracking of tolerance following clinical transplantation to serve as biomarkers. This review may enable a personalized assessment of the degree of tolerance in individual patients and the opportunity to strengthen the robustness of peripheral tolerance.
自发现新生儿耐受以来,人们一直致力于寻找一种方法,即在实现供者特异性移植耐受(即能够摆脱免疫抑制剂但仍保持对非移植物抗原的免疫能力)的同时,使免疫功能得以保留。最近,人们不仅致力于了解如何诱导移植耐受,还致力于研究维持耐受所需的机制以及炎症暴露如何挑战其持久性。本综述重点关注 T 细胞耐受的关键外周机制的最新进展,其基本假设是,这些机制中的几种联合作用可能提供更强大、更持久的耐受,而对这些单独途径的更好理解可能允许对临床移植后的耐受进行纵向跟踪,作为生物标志物。本综述可能有助于对个体患者的耐受程度进行个性化评估,并提供加强外周耐受稳健性的机会。